ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2022

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease.

Amal A Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.